Hyperbaric oxygen improves healing in experimental rat colitis
- PMID: 12797669
Hyperbaric oxygen improves healing in experimental rat colitis
Abstract
This study was designed to investigate therapeutic effects of hyperbaric oxygen on experimentally induced colitis in rats by assessing oxidative tissue damage, neutrophil accumulation and histological changes. Six groups of animals were used. No procedures were done in the sham group. In the vehicle group, 50% ethanol-induced colitis, and in four other groups, 2,4,6-trinitrobenzene sulphonic acid-induced colonic inflammation was achieved. In acute and chronic colitis non-treatment groups, no other procedure was done. In acute and chronic colitis hyperbaric oxygen treatment groups, rats underwent hyperbaric oxygen treatment for two or fourteen days. On the third and fifteenth days respectively tissue and blood samples were taken for microscopic and macroscopic damage assessment, myeloperoxidase activity and serum carbonyl content measurements. There was significant colonic tissue damage in non-treatment groups at 48 hours and 14 days. Hyperbaric oxygen treatment ameliorated the macroscopic damage significantly in chronic colitis. Amelioration of microscopic changes was not significant in each hyperbaric oxygen-treated group. Hyperbaric oxygen treatment significantly reduced tissue myeloperoxidase activity in acute colitis and decreased plasma carbonyl content in chronic colitis. In the present study, hyperbaric oxygen treatment significantly ameliorated trinitrobenzene sulphonic acid-induced chronic colitis in rats.
Similar articles
-
Effects of statins on experimental colitis in normocholesterolemic rats.Scand J Gastroenterol. 2006 Aug;41(8):954-62. doi: 10.1080/00365520600554444. Scand J Gastroenterol. 2006. PMID: 16803694
-
Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis.Eur J Gastroenterol Hepatol. 1997 Dec;9(12):1205-11. Eur J Gastroenterol Hepatol. 1997. PMID: 9471027
-
Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats.J Gastroenterol Hepatol. 2007 Nov;22(11):1859-65. doi: 10.1111/j.1440-1746.2006.04504.x. J Gastroenterol Hepatol. 2007. PMID: 17914960
-
[Hyperbaric oxygen treatment].Tidsskr Nor Laegeforen. 1965 Apr 1;85(7):593-8. Tidsskr Nor Laegeforen. 1965. PMID: 5320342 Review. Norwegian. No abstract available.
-
Toxic and therapeutic properties of oxygen--a review.Sb Lek. 1995;96(3):231-4. Sb Lek. 1995. PMID: 8718813 Review. No abstract available.
Cited by
-
Hyperbaric oxygen therapy is as effective as dexamethasone in the treatment of TNBS-E-induced experimental colitis.Dig Dis Sci. 2008 Feb;53(2):481-5. doi: 10.1007/s10620-007-9956-4. Epub 2007 Oct 13. Dig Dis Sci. 2008. PMID: 17934837
-
Bench-to-bedside review: oxygen as a drug.Crit Care. 2009;13(1):205. doi: 10.1186/cc7151. Epub 2009 Feb 24. Crit Care. 2009. PMID: 19291278 Free PMC article. Review.
-
Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis.Med Gas Res. 2012 Mar 15;2(1):6. doi: 10.1186/2045-9912-2-6. Med Gas Res. 2012. PMID: 22417628 Free PMC article.
-
Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series.BMJ Open Gastroenterol. 2016 Apr 28;3(1):e000082. doi: 10.1136/bmjgast-2016-000082. eCollection 2016. BMJ Open Gastroenterol. 2016. PMID: 27195128 Free PMC article.
-
The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis.Dig Dis Sci. 2009 Jan;54(1):75-9. doi: 10.1007/s10620-008-0498-1. Epub 2008 Oct 30. Dig Dis Sci. 2009. PMID: 18972208
MeSH terms
Substances
LinkOut - more resources
Research Materials